Gainers
- Acutus Medical AFIB stock increased by 111.7% to $1.14 during Monday's pre-market session. The company's market cap stands at $32.3 million.
- Evofem Biosciences EVFM shares moved upwards by 73.43% to $0.65. The company's market cap stands at $22.8 million.
- Epizyme EPZM shares rose 63.52% to $1.56. The company's market cap stands at $257.2 million.
- Tenax Therapeutics TENX shares increased by 51.41% to $0.47. The company's market cap stands at $11.8 million.
- Axsome Therapeutics AXSM stock moved upwards by 51.06% to $36.95. The market value of their outstanding shares is at $1.4 billion.
- Agile Therapeutics AGRX stock moved upwards by 43.46% to $1.65. The company's market cap stands at $7.4 million.
Losers
- Benitec Biopharma BNTC shares declined by 13.1% to $1.06 during Monday's pre-market session. The company's market cap stands at $8.6 million.
- Nuvation Bio NUVB stock decreased by 10.98% to $3.73. The market value of their outstanding shares is at $817.0 million.
- Chimerix CMRX shares decreased by 10.68% to $1.84. The company's market cap stands at $160.8 million.
- SIGA Technologies SIGA stock fell 10.05% to $11.73. The market value of their outstanding shares is at $849.3 million.
- CymaBay Therapeutics CBAY stock declined by 7.81% to $2.6. The company's market cap stands at $220.1 million.
- China SXT Pharmaceuticals SXTC stock declined by 7.7% to $1.8. The company's market cap stands at $3.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AGRXAgile Therapeutics Inc COM PAR $0.0001
$1.49-1.32%
AXSMAxsome Therapeutics Inc
$104.000.86%
BNTCBenitec Biopharma Inc
$10.75-%
CMRXChimerix Inc
$3.90-1.52%
EVFMEvofem Biosciences Inc
$0.0122-97.5%
NUVBNuvation Bio Inc
$2.51-0.40%
SIGASIGA Technologies Inc
$6.45-%
SXTCChina SXT Pharmaceuticals Inc
$0.45916.25%
TENXTenax Therapeutics Inc
$6.52-0.46%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in